Mirae Asset Global Investments Co., Ltd. Standard Biotools Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$1.85 - $5.29 $51,594 - $147,532	-27,889 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$1.24 - $4.35 $3,917 - $13,741	3,159 Added 12.77%	27,889 $71,000
Q4 2019 Feb 12, 2020	BUY	$2.3 - $5.12 $5,250 - $11,688	2,283 Added 10.17%	24,730 $86,000
Q3 2019 Nov 12, 2019	BUY	$4.63 - $12.15 $103,929 - $272,731	22,447 New	22,447 $104,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $126M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.